Skip to content
Feral Cat LogoGovInfoNow
FDA drug shortage status

Is Imipenem and Cilastatin Injection (Primaxin Iv) in shortage?

Imipenem and Cilastatin Injection is listed by FDA as being discontinued by at least one maker (updated Jan 8, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Primaxin, Injection, 500mg (NDC 0006-3516-59)
    Merck Sharp & Dohme Corp.Being discontinuedUpdated Jan 8, 2026Discontinued Jan 8, 2026

    To be discontinued approximately 11/30/2026

    Maker contact: 800-672-6372

Imipenem and Cilastatin Injection shortage questions

Is Imipenem and Cilastatin Injection (Primaxin Iv) in shortage?

Imipenem and Cilastatin Injection is listed by FDA as being discontinued by at least one maker (updated Jan 8, 2026).

What should I do if I can’t get Imipenem and Cilastatin Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.